Mobile App-linked Next Gen Device for Remote Monitoring

Dr. Balbir Singh, Chairman, Head of Cardiology, Max Super Specialty Hospital, Saket & team has successfully implanted a mobile app-linked, and Gallant technology-based cardioverter defibrillator in a 56-year old male patient, on 29th February, girfting him the assurance with his medical team.

Though belonging to the family of Implantable Cardioverter Defibrillators (ICDs), the implanted ne is a next-generation device (from Abbott's Gallant technology) that offers Bluetooth connectivity and a patient smartphone app. It was approved by the US FDA in July this year.

The implant procedure was performed by a team of medical exports, under the leadership of Dr Babir Singh, Chairman, Cardiac Sciences, Max Super Speciality Hospital, Saket. The patient was from a remote location in Northern India. He Presented at Max Hospital, Delhi, with complaints of presyncope, lightheadedness or the sensation of feeling faint without actually fainting. The patient had earlier undergone a Coronary Artery Bypass Grafting surgery, a procedure to improve por blood flow to the heart. At the time of admission, the ejection fration (LVEF) of his left ventricle was 35% - which meant that the outflow of blood from the heart,  each time it contracted, was low.

Benefits of the ICD implant -

• The new Gallant ICDs bring the most advanced heart rhythm management capabilities for people with abnormal heart rhythms and heart failure
• They enable clinicians to monitor patients remotely and identify episodes of life-threatening abnormal heart rates in them
• These features help clinicians to be ready with medical interventions
• Gallant ICDs also prove useful during the Pandemic as they help physicians catch undiagnosed heart abnormalities in patients who are not able to avail routine checkups